Skoči na glavni sadržaj

Pregledni rad

https://doi.org/10.21860/medflum2024_316225

Hyperparathyreoidism After Kidney Transplantation

Lidija Orlić orcid id orcid.org/0000-0001-8376-6623 ; Klinički bolnički centar Rijeka, Zavod za nefrologiju, dijalizu i transplantaciju bubrega, Rijeka, Hrvatska *

* Dopisni autor.


Puni tekst: hrvatski pdf 4.443 Kb

str. 176-183

preuzimanja: 231

citiraj


Sažetak

After successful kidney transplantation, the recovery of exocrine and endocrine kidney function occurs. Serum calcium, parathyroid hormone (PTH) phosphate, fibroblast growth factor 23 (FGF-23) and vitamin D values normalize. Therefore, positive changes in bone metabolism improve bone quality, reducing the frequency of fractures and vascular calcifications. In some patients, despite successful transplantation, disorders in bone metabolism remain. The incidence of hyperparathyroidism (HPT) after the first year of kidney transplantation ranges from 10-50%. The duration of dialysis and the degree of hyperplasia of the parathyroid glands are risk factors for the development of posttransplant HPT. The treatment of posttransplant HPT includes vitamin D therapy, vitamin D analogs, calcimimetics and parathyroidectomy (PTX).

Ključne riječi

Calcium; Hyperparathyroidism; Kidney Transplantation; Parathyroid Hormone; Parathyroidectomy; Vitamin D

Hrčak ID:

316225

URI

https://hrcak.srce.hr/316225

Datum izdavanja:

1.6.2024.

Podaci na drugim jezicima: hrvatski

Posjeta: 678 *